Clinical Trial

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the use of rapamycin cream can be used as a treatment together with pulsed dyed laser in treating port wine stain birthmarks. The main question it aims to answer is: Will rapamycin cream and laser treatment show a greater improvement in appearance of port wine birthmarks, compared to treatment with placebo cream and laser? Researchers will compare two concentrations of rapamycin cream (0.6% or 1.0%) with placebo treatment to see if appearance is improved following 12 weeks of treatment. Participants will receive laser treatment of their port wine birthmark and then apply the rapamycin or placebo cream daily for 12 weeks. Patients will visit the clinic every 4 weeks for checkups and tests.
Protocol Amendment History 1 change
notable Primary completion pushed: 2027-09 -> 2027-10 2026-07-02
Trial Details
NCT Number NCT07436611
Lead Sponsor AFT Pharmaceuticals, Ltd.
Conditions Port Wine Stains
Enrollment 30 participants
Start Date 2026-08
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-01